SKF-38393 HBr

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

SKF-38393 HBr

Specification
Cat. No.
SMD035
Related Diseases
Anorexia
Product Name
SKF-38393 HBr
Size
200.0mg; 500.0mg; 1.0g; 2.0g; 5.0g
Price
Inquiry
Availability
2 Weeks
Description
SKF-38393, aslo known as (+/-)-SKF-38393, is a synthetic compound of the benzazepine chemical class which acts as a selective D1/D5 receptor partial agonist. It has stimulant and anorectic effects. SKF 38393 improves temporal order memory performance in maternally deprived rats. SKF 38393 reverses cocaine-conditioned place preference in mice. SKF 38393 induces GAP-43 expression and long-term potentiation in hippocampus in vivo.
CAS Number
20012-10-6 (HBr)
Chemical Formula
C16H18BrNO2
Molecular Weight
336.229
Elemental Analysis
C, 57.16; H, 5.40; Br, 23.76; N, 4.17; O, 9.52
Synonym
67287-49-4 (free base), 62717-42-4 (HCl), 81702-42-3 (R-isomer HCl), 62751-59-1 (R-isomer), 20012-10-6 (HBr),
IUPAC/Chemical Name
1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide
InChi Key
INNWVRBZMBCEJI-UHFFFAOYSA-N
InChi Code
InChI=1S/C16H17NO2.BrH/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11;/h1-5,8-9,14,17-19H,6-7,10H2;1H
SMILES Code
OC1=C(O)C=C2C(C3=CC=CC=C3)CNCCC2=C1.[H]Br
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top